These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22847257)

  • 21. Comparative analysis of the revised Directive 2010/63/EU for the protection of laboratory animals with its predecessor 86/609/EEC - a t4 report.
    Hartung T
    ALTEX; 2010; 27(4):285-303. PubMed ID: 21240470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():91-109. PubMed ID: 19025334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An integrated decision-tree testing strategy for skin sensitisation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2007 Dec; 35(6):683-97. PubMed ID: 18186673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):45-63. PubMed ID: 18333714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An integrated decision-tree testing strategy for eye irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():111-22. PubMed ID: 19025335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The EU REACH system: blessing in disguise or wolf in wolf's clothing?
    Bhogal N
    Altern Lab Anim; 2005 Apr; 33(2):81-2. PubMed ID: 16180983
    [No Abstract]   [Full Text] [Related]  

  • 30. Integrated decision-tree testing strategies for environmental toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():29-42. PubMed ID: 19025330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuing animal tests on cosmetic ingredients for REACH in the EU.
    Knight J; Rovida C; Kreiling R; Zhu C; Knudsen M; Hartung T
    ALTEX; 2021; 38(4):653-668. PubMed ID: 34402521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New EU legislation for risk assessment of GM food: no scientific justification for mandatory animal feeding trials.
    Kuiper HA; Kok EJ; Davies HV
    Plant Biotechnol J; 2013 Sep; 11(7):781-4. PubMed ID: 23786622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated decision-tree testing strategies for mutagenicity and carcinogenicity with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():43-63. PubMed ID: 19025331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging food safety issues: An EU perspective.
    McEvoy JD
    Drug Test Anal; 2016 May; 8(5-6):511-20. PubMed ID: 27443205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European perspectives of food safety.
    Bánáti D
    J Sci Food Agric; 2014 Aug; 94(10):1941-6. PubMed ID: 24515443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chair on alternatives?
    Spielmann H
    ALTEX; 2002; 19(2):69-73. PubMed ID: 12098012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human health safety evaluation of cosmetics in the EU: a legally imposed challenge to science.
    Pauwels M; Rogiers V
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):260-74. PubMed ID: 20006634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU.
    Lindl T; Gross U; Ruhdel I; von Aulock S; Völkel M
    ALTEX; 2012; 29(2):219-28. PubMed ID: 22562491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.